155 related articles for article (PubMed ID: 21775422)
1. Forced dimerization increases the activity of ΔEGFR/EGFRvIII and enhances its oncogenicity.
Hwang Y; Chumbalkar V; Latha K; Bogler O
Mol Cancer Res; 2011 Sep; 9(9):1199-208. PubMed ID: 21775422
[TBL] [Abstract][Full Text] [Related]
2. Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.
Latha K; Li M; Chumbalkar V; Gururaj A; Hwang Y; Dakeng S; Sawaya R; Aldape K; Cavenee WK; Bogler O; Furnari FB
Int J Cancer; 2013 Feb; 132(3):509-20. PubMed ID: 22729867
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells.
Fernandes H; Cohen S; Bishayee S
J Biol Chem; 2001 Feb; 276(7):5375-83. PubMed ID: 11087732
[TBL] [Abstract][Full Text] [Related]
4. Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of ΔEGFR.
Chumbalkar V; Latha K; Hwang Y; Maywald R; Hawley L; Sawaya R; Diao L; Baggerly K; Cavenee WK; Furnari FB; Bogler O
J Proteome Res; 2011 Mar; 10(3):1343-52. PubMed ID: 21214269
[TBL] [Abstract][Full Text] [Related]
5. Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.
Garnett J; Chumbalkar V; Vaillant B; Gururaj AE; Hill KS; Latha K; Yao J; Priebe W; Colman H; Elferink LA; Bogler O
Neoplasia; 2013 Jan; 15(1):73-84. PubMed ID: 23359207
[TBL] [Abstract][Full Text] [Related]
6. EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway.
Bonavia R; Inda MM; Vandenberg S; Cheng SY; Nagane M; Hadwiger P; Tan P; Sah DW; Cavenee WK; Furnari FB
Oncogene; 2012 Sep; 31(36):4054-66. PubMed ID: 22139077
[TBL] [Abstract][Full Text] [Related]
7. Access to the nucleus and functional association with c-Myc is required for the full oncogenic potential of ΔEGFR/EGFRvIII.
Gururaj AE; Gibson L; Panchabhai S; Bai M; Manyam G; Lu Y; Latha K; Rojas ML; Hwang Y; Liang S; Bogler O
J Biol Chem; 2013 Feb; 288(5):3428-38. PubMed ID: 23250739
[TBL] [Abstract][Full Text] [Related]
8. Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence.
Mukasa A; Wykosky J; Ligon KL; Chin L; Cavenee WK; Furnari F
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2616-21. PubMed ID: 20133782
[TBL] [Abstract][Full Text] [Related]
9. An EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII.
Li L; Chakraborty S; Yang CR; Hatanpaa KJ; Cipher DJ; Puliyappadamba VT; Rehman A; Jiwani AJ; Mickey B; Madden C; Raisanen J; Burma S; Saha D; Wang Z; Pingle SC; Kesari S; Boothman DA; Habib AA
Oncogene; 2014 Aug; 33(33):4253-64. PubMed ID: 24077285
[TBL] [Abstract][Full Text] [Related]
10. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
Wu CJ; Qian X; O'Rourke DM
DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
[TBL] [Abstract][Full Text] [Related]
11. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.
Huang HS; Nagane M; Klingbeil CK; Lin H; Nishikawa R; Ji XD; Huang CM; Gill GN; Wiley HS; Cavenee WK
J Biol Chem; 1997 Jan; 272(5):2927-35. PubMed ID: 9006938
[TBL] [Abstract][Full Text] [Related]
12. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway.
Prigent SA; Nagane M; Lin H; Huvar I; Boss GR; Feramisco JR; Cavenee WK; Huang HS
J Biol Chem; 1996 Oct; 271(41):25639-45. PubMed ID: 8810340
[TBL] [Abstract][Full Text] [Related]
13. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.
Inda MM; Bonavia R; Mukasa A; Narita Y; Sah DW; Vandenberg S; Brennan C; Johns TG; Bachoo R; Hadwiger P; Tan P; Depinho RA; Cavenee W; Furnari F
Genes Dev; 2010 Aug; 24(16):1731-45. PubMed ID: 20713517
[TBL] [Abstract][Full Text] [Related]
14. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the mutant epidermal growth factor, deltaEGFR, in glioblastoma.
Nishikawa R; Sugiyama T; Narita Y; Furnari F; Cavenee WK; Matsutani M
Brain Tumor Pathol; 2004; 21(2):53-6. PubMed ID: 15700833
[TBL] [Abstract][Full Text] [Related]
16. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK
Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases.
Nagane M; Levitzki A; Gazit A; Cavenee WK; Huang HJ
Proc Natl Acad Sci U S A; 1998 May; 95(10):5724-9. PubMed ID: 9576951
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization.
Schmidt MHH; Furnari FB; Cavenee WK; Bögler O
Proc Natl Acad Sci U S A; 2003 May; 100(11):6505-10. PubMed ID: 12734385
[TBL] [Abstract][Full Text] [Related]
19. Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII).
Chu CT; Everiss KD; Wikstrand CJ; Batra SK; Kung HJ; Bigner DD
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):855-61. PubMed ID: 9210410
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts.
Johnson H; Del Rosario AM; Bryson BD; Schroeder MA; Sarkaria JN; White FM
Mol Cell Proteomics; 2012 Dec; 11(12):1724-40. PubMed ID: 22964225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
